作者
Sean J. Barbour,Rosanna Coppo,Lee Er,Évangéline Pillebout,María Luisa Russo,Charles E. Alpers,Agnes B. Fogo,Franco Ferrario,J. Charles Jennette,Ian S. Roberts,H. Terence Cook,Jie Ding,Baige Su,Xing Zhong,Fernando C. Fervenza,Ladan Zand,Licia Peruzzi,Laura Lucchetti,Ritsuko Katafuchi,Yuko Shima,Norishige Yoshikawa,Daisuke Ichikawa,Yusuke Suzuki,Luisa Murer,Robert Wyatt,Raoul D. Nelson,JoAnn Hansen Narus,Scott E. Wenderfer,Duvuru Geetha,Éric Daugas,Renato C. Monteiro,Shinya Nakatani,Antonio Mastrangelo,Matti Nuutinen,Mikael Koskela,Lutz T. Weber,Ágnes Hackl,Martin Pöhl,Carmine Pecoraro,Nobuyuki Tsuboi,Takashi Yokoo,Toshiko Ito,Shouichi Fujimoto,Giovanni Conti,Domenico Santoro,Marco Materassi,Hong Zhang,Sufang Shi,Fei Liu,Vladimı́r Tesař,Dita Maixnerová,Carmen Ávila-Casado,Ingeborg M. Bajema,Antonella Barreca,Jan Ulrich Becker,Jessica Comstock,Virgilius Cornea,Karen W. Eldin,Loren Herrera Hernandez,Jean Hou,Kensuke Joh,Mercury Lin,Nidia Messias,Andrea Onetti Muda,Fabio Pagni,Francesca Diomedi Camassei,Heikki Tokola,Maria DʼArmiento,Maximilian Seidl,Avi Z. Rosenberg,Aurélie Sannier,Maria Fernanda Soares,Suxia Wang,Caihong Zeng,Mark Haas
摘要
Nephritis is a common manifestation of IgA vasculitis and is morphologically indistinguishable from IgA nephropathy. While MEST-C scores are predictive of kidney outcomes in IgA nephropathy, their value in IgA vasculitis nephritis has not been investigated in large multiethnic cohorts.Biopsies from 262 children and 99 adults with IgA vasculitis nephritis (N=361) from 23 centers in North America, Europe and Asia were independently scored by 3 pathologists. MEST-C scores were assessed for correlation with eGFR/proteinuria at biopsy. Because most patients (N=309, 86%) received immunosuppression, risk factors for outcomes were evaluated in this group using Latent Class Mixed Models (LCMM) to identify classes of eGFR trajectories over a median follow-up of 2.7 years (IQR 1.2, 5.1). Clinical and histologic parameters associated with each class were determined using logistic regression.M, E, T and C scores were correlated with either eGFR or proteinuria at biopsy. Two classes were identified by LCMM, one with initial improvement in eGFR followed by a late decline (Class 1, N=91) and another with stable eGFR (Class 2, N=218). Class 1 was associated with a higher risk of an established kidney outcome (time to >30% decline in eGFR or kidney failure, HR 5.84, 95%CI 2.37, 14.4). Among MEST-C scores, only E1 was associated with Class 1 by multivariable analysis. Other factors associated with Class 1 were age <18 years, male sex, lower eGFR at biopsy, and extrarenal non-cutaneous disease. Fibrous crescents without active changes were associated with Class 2.Kidney outcome in patients with biopsied IgA vasculitis nephritis treated with immunosuppression was determined by clinical risk factors, and endocapillary hypercellularity (E1) and fibrous crescents, which are features that are not part of the ISKDC classification..